Global Angiotensin II Receptor Blocker (ARBs) API Market Growth (Status and Outlook) 2022-2028
- LP 4887728
- 100 Pages
- March 2022
- Medical Devices
The United States Angiotensin II Receptor Blocker (ARBs) API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Angiotensin II Receptor Blocker (ARBs) API market, reaching US$ million by the year 2028. As for the Europe Angiotensin II Receptor Blocker (ARBs) API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Angiotensin II Receptor Blocker (ARBs) API players cover Teva Pharmaceutical, Aurobindo Pharma, Viatris, and Tianyu Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Angiotensin II Receptor Blocker (ARBs) API market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Valsartan
Irbesartan
Telmisartan
Losartan
Candesartan
Olmesartan
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Essential Hypertension
Secondary Hypertension
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Teva Pharmaceutical
Aurobindo Pharma
Viatris
Tianyu Pharma
Huahai Pharmaceutical
Menovo
Rundu Pharma
Kinglyuan Pharmaceutical
Second Pharma
Apeloa
Jiangxi Synergy Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size 2017-2028
2.1.2 Angiotensin II Receptor Blocker (ARBs) API Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Angiotensin II Receptor Blocker (ARBs) API Segment by Type
2.2.1 Valsartan
2.2.2 Irbesartan
2.2.3 Telmisartan
2.2.4 Losartan
2.2.5 Candesartan
2.2.6 Olmesartan
2.2.7 Others
2.3 Angiotensin II Receptor Blocker (ARBs) API Market Size by Type
2.3.1 Angiotensin II Receptor Blocker (ARBs) API Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type (2017-2022)
2.4 Angiotensin II Receptor Blocker (ARBs) API Segment by Application
2.4.1 Essential Hypertension
2.4.2 Secondary Hypertension
2.5 Angiotensin II Receptor Blocker (ARBs) API Market Size by Application
2.5.1 Angiotensin II Receptor Blocker (ARBs) API Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application (2017-2022)
3 Angiotensin II Receptor Blocker (ARBs) API Market Size by Player
3.1 Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Players
3.1.1 Global Angiotensin II Receptor Blocker (ARBs) API Revenue by Players (2020-2022)
3.1.2 Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Players (2020-2022)
3.2 Global Angiotensin II Receptor Blocker (ARBs) API Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Angiotensin II Receptor Blocker (ARBs) API by Regions
4.1 Angiotensin II Receptor Blocker (ARBs) API Market Size by Regions (2017-2022)
4.2 Americas Angiotensin II Receptor Blocker (ARBs) API Market Size Growth (2017-2022)
4.3 APAC Angiotensin II Receptor Blocker (ARBs) API Market Size Growth (2017-2022)
4.4 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Growth (2017-2022)
4.5 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Growth (2017-2022)
5 Americas
5.1 Americas Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2017-2022)
5.2 Americas Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022)
5.3 Americas Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2017-2022)
6.2 APAC Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022)
6.3 APAC Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Angiotensin II Receptor Blocker (ARBs) API by Country (2017-2022)
7.2 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022)
7.3 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API by Region (2017-2022)
8.2 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022)
8.3 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.1 Global Angiotensin II Receptor Blocker (ARBs) API Forecast by Regions (2023-2028)
10.1.1 Global Angiotensin II Receptor Blocker (ARBs) API Forecast by Regions (2023-2028)
10.1.2 Americas Angiotensin II Receptor Blocker (ARBs) API Forecast
10.1.3 APAC Angiotensin II Receptor Blocker (ARBs) API Forecast
10.1.4 Europe Angiotensin II Receptor Blocker (ARBs) API Forecast
10.1.5 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Forecast
10.2 Americas Angiotensin II Receptor Blocker (ARBs) API Forecast by Country (2023-2028)
10.2.1 United States Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.2.2 Canada Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.2.3 Mexico Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.2.4 Brazil Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.3 APAC Angiotensin II Receptor Blocker (ARBs) API Forecast by Region (2023-2028)
10.3.1 China Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.3.2 Japan Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.3.3 Korea Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.3.4 Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.3.5 India Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.3.6 Australia Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.4 Europe Angiotensin II Receptor Blocker (ARBs) API Forecast by Country (2023-2028)
10.4.1 Germany Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.4.2 France Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.4.3 UK Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.4.4 Italy Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.4.5 Russia Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.5 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Forecast by Region (2023-2028)
10.5.1 Egypt Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.5.2 South Africa Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.5.3 Israel Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.5.4 Turkey Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.5.5 GCC Countries Angiotensin II Receptor Blocker (ARBs) API Market Forecast
10.6 Global Angiotensin II Receptor Blocker (ARBs) API Forecast by Type (2023-2028)
10.7 Global Angiotensin II Receptor Blocker (ARBs) API Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Information
11.1.2 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.1.3 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Pharmaceutical Main Business Overview
11.1.5 Teva Pharmaceutical Latest Developments
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Information
11.2.2 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.2.3 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Aurobindo Pharma Main Business Overview
11.2.5 Aurobindo Pharma Latest Developments
11.3 Viatris
11.3.1 Viatris Company Information
11.3.2 Viatris Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.3.3 Viatris Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Viatris Main Business Overview
11.3.5 Viatris Latest Developments
11.4 Tianyu Pharma
11.4.1 Tianyu Pharma Company Information
11.4.2 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.4.3 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Tianyu Pharma Main Business Overview
11.4.5 Tianyu Pharma Latest Developments
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Information
11.5.2 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.5.3 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Huahai Pharmaceutical Main Business Overview
11.5.5 Huahai Pharmaceutical Latest Developments
11.6 Menovo
11.6.1 Menovo Company Information
11.6.2 Menovo Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.6.3 Menovo Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Menovo Main Business Overview
11.6.5 Menovo Latest Developments
11.7 Rundu Pharma
11.7.1 Rundu Pharma Company Information
11.7.2 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.7.3 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Rundu Pharma Main Business Overview
11.7.5 Rundu Pharma Latest Developments
11.8 Kinglyuan Pharmaceutical
11.8.1 Kinglyuan Pharmaceutical Company Information
11.8.2 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.8.3 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Kinglyuan Pharmaceutical Main Business Overview
11.8.5 Kinglyuan Pharmaceutical Latest Developments
11.9 Second Pharma
11.9.1 Second Pharma Company Information
11.9.2 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.9.3 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Second Pharma Main Business Overview
11.9.5 Second Pharma Latest Developments
11.10 Apeloa
11.10.1 Apeloa Company Information
11.10.2 Apeloa Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.10.3 Apeloa Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Apeloa Main Business Overview
11.10.5 Apeloa Latest Developments
11.11 Jiangxi Synergy Pharmaceutical
11.11.1 Jiangxi Synergy Pharmaceutical Company Information
11.11.2 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
11.11.3 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Jiangxi Synergy Pharmaceutical Main Business Overview
11.11.5 Jiangxi Synergy Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Table 1. Angiotensin II Receptor Blocker (ARBs) API Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Valsartan
Table 3. Major Players of Irbesartan
Table 4. Major Players of Telmisartan
Table 5. Major Players of Losartan
Table 6. Major Players of Candesartan
Table 7. Major Players of Olmesartan
Table 8. Major Players of Others
Table 9. Angiotensin II Receptor Blocker (ARBs) API Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type (2017-2022)
Table 12. Angiotensin II Receptor Blocker (ARBs) API Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application (2017-2022)
Table 15. Global Angiotensin II Receptor Blocker (ARBs) API Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Player (2020-2022)
Table 17. Angiotensin II Receptor Blocker (ARBs) API Key Players Head office and Products Offered
Table 18. Angiotensin II Receptor Blocker (ARBs) API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Regions (2017-2022)
Table 23. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Country (2017-2022)
Table 25. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type (2017-2022)
Table 27. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application (2017-2022)
Table 29. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Region (2017-2022)
Table 31. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type (2017-2022)
Table 33. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application (2017-2022)
Table 35. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Country (2017-2022)
Table 37. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type (2017-2022)
Table 39. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Angiotensin II Receptor Blocker (ARBs) API
Table 48. Key Market Challenges & Risks of Angiotensin II Receptor Blocker (ARBs) API
Table 49. Key Industry Trends of Angiotensin II Receptor Blocker (ARBs) API
Table 50. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share Forecast by Application (2023-2028)
Table 56. Teva Pharmaceutical Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 57. Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 58. Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Teva Pharmaceutical Main Business
Table 60. Teva Pharmaceutical Latest Developments
Table 61. Aurobindo Pharma Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 62. Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 63. Aurobindo Pharma Main Business
Table 64. Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Aurobindo Pharma Latest Developments
Table 66. Viatris Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 67. Viatris Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 68. Viatris Main Business
Table 69. Viatris Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Viatris Latest Developments
Table 71. Tianyu Pharma Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 72. Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 73. Tianyu Pharma Main Business
Table 74. Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Tianyu Pharma Latest Developments
Table 76. Huahai Pharmaceutical Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 77. Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 78. Huahai Pharmaceutical Main Business
Table 79. Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Huahai Pharmaceutical Latest Developments
Table 81. Menovo Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 82. Menovo Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 83. Menovo Main Business
Table 84. Menovo Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Menovo Latest Developments
Table 86. Rundu Pharma Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 87. Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 88. Rundu Pharma Main Business
Table 89. Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Rundu Pharma Latest Developments
Table 91. Kinglyuan Pharmaceutical Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 92. Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 93. Kinglyuan Pharmaceutical Main Business
Table 94. Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Kinglyuan Pharmaceutical Latest Developments
Table 96. Second Pharma Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 97. Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 98. Second Pharma Main Business
Table 99. Second Pharma Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Second Pharma Latest Developments
Table 101. Apeloa Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 102. Apeloa Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 103. Apeloa Main Business
Table 104. Apeloa Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Apeloa Latest Developments
Table 106. Jiangxi Synergy Pharmaceutical Details, Company Type, Angiotensin II Receptor Blocker (ARBs) API Area Served and Its Competitors
Table 107. Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product Offered
Table 108. Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Jiangxi Synergy Pharmaceutical Main Business
Table 110. Jiangxi Synergy Pharmaceutical Latest Developments
List of Figures
Figure 1. Angiotensin II Receptor Blocker (ARBs) API Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type in 2021
Figure 7. Angiotensin II Receptor Blocker (ARBs) API in Essential Hypertension
Figure 8. Global Angiotensin II Receptor Blocker (ARBs) API Market: Essential Hypertension (2017-2022) & ($ Millions)
Figure 9. Angiotensin II Receptor Blocker (ARBs) API in Secondary Hypertension
Figure 10. Global Angiotensin II Receptor Blocker (ARBs) API Market: Secondary Hypertension (2017-2022) & ($ Millions)
Figure 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application in 2021
Figure 12. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Player in 2021
Figure 13. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size 2017-2022 ($ Millions)
Figure 15. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size 2017-2022 ($ Millions)
Figure 16. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size 2017-2022 ($ Millions)
Figure 18. Americas Angiotensin II Receptor Blocker (ARBs) API Value Market Share by Country in 2021
Figure 19. Americas Angiotensin II Receptor Blocker (ARBs) API Consumption Market Share by Type in 2021
Figure 20. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application in 2021
Figure 21. United States Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Region in 2021
Figure 26. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application in 2021
Figure 27. China Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Country in 2021
Figure 34. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type in 2021
Figure 35. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application in 2021
Figure 36. Germany Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Market Share by Application in 2021
Figure 44. Egypt Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Angiotensin II Receptor Blocker (ARBs) API Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 50. APAC Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 51. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 53. United States Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 54. Canada Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 57. China Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 58. Japan Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 59. Korea Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 61. India Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 62. Australia Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 63. Germany Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 64. France Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 65. UK Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 66. Italy Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 67. Russia Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 68. Spain Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 71. Israel Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Angiotensin II Receptor Blocker (ARBs) API Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
